Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations.

The American journal of cardiology - 1 Jul 2020

Shah Nishant P, Pajidipati Neha J, McGarrah Robert W, Navar Ann Marie, Vemulapalli Sreekanth, Blazing Michael A, Shah Svati H, Hernandez Adrian F, Patel Manesh R

Abstract excerpt

Lipoprotein (a) [Lp(a)] is a low-density, cholesterol-containing lipoprotein that differs from other low-density lipoproteins due to the presence of apolipoprotein(a) bound to its surface apolipoprotein B100. Multiple epidemiologic studies, including Mendelian Randomization studies, have demonstrated that increasing Lp(a) levels are associated with increased risk of heart disease, including atherosclerotic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Component Removal
Share to Diabetes Mellitus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lipoprotein(a)

Share to Oligonucleotides, Antisense

Share to Peripheral Arterial Disease

Share to Primary Prevention

Share to Secondary Prevention

Share to Stroke

Source

Open in PubMed Open full text

Identifiers

PMID: 32336532
DOI: 10.1016/j.amjcard.2020.03.043
PMCID: PMC7376542

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations.PMID 32336532Read ↗

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.Semantic proximity Read ↗

Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) MoleculeSemantic proximity Read ↗

Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular DiseaseSemantic proximity Read ↗

Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapiesSemantic proximity Read ↗

Targeting Lipoprotein(a): A New Era in Cardiovascular Disease Prevention.Semantic proximity Read ↗

Lipoprotein(a): new insights from modern genomicsSemantic proximity Read ↗

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?Semantic proximity Read ↗

Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factorSemantic proximity Read ↗

LP(a): Structure, Genetics, Associated Cardiovascular Risk, and Emerging TherapeuticsSemantic proximity Read ↗

Lipoprotein(a): Bridging the Gap Between Screening and Treatment—A Narrative ReviewSemantic proximity Read ↗

Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment PerspectivesSemantic proximity Read ↗

Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarctionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.